Endocrinology

EMD Serono is dedicated to researching and bringing meaningful solutions to patients impacted by select endocrine disorders such as HIV-associated wasting.


A Need for HIV Patients

In the 1980s/1990s, an AIDS or HIV diagnosis was a scary prospect  - an incurable disease that could lead to mortality for many.

Years later, the advent of new anti-retroviral medications helped most AIDS and HIV positive patients successfully manage their condition. Despite this advance, a subset of patients taking HIV medication found that they still experienced a decrease in energy, lean body mass and lost weight without trying - a condition known as HIV-associated wasting.

The approval of Serostim® (somatropin) for injection by the Food and Drug Administration brought a therapeutic option to HIV and AIDS patients impacted by wasting. As a recombinant growth hormone, its approval underscored the "outside the box" thinking that remains a hallmark at EMD Serono today as we work to bring meaningful solutions to patients.

Important Risk Information

Serostim is an injectable prescription medicine used to treat HIV-positive patients with wasting or cachexia. Serostim can only be used by people receiving treatment for the HIV infection.

Serostim should not be used if you have a critical illness, serious injury, severe breathing problem, surgery complications, eye problems caused by high blood sugar, or an allergy to the drug or diluent.

Patients using Serostim may experience swelling, serious allergic reactions that require medical attention, bone, muscle, and joint pain or stiffness, tingling, numbness, upset stomach, and extreme tiredness. Breast enlargement may also occur in men. Other more serious and less common side effects include high blood sugar, hypersensitivity and pancreatitis. Other side effects may occur. For complete product details and risks, please refer to the full Prescribing Information and talk to your doctor if you have questions or experience side effects using Serostim.

Serostim® (somatropin) for injection: Full prescribing information (PDF)

unwavering commitment to the HIV community

The AXIS Center®: Our Patient Support Program

EMD Serono has shown an unwavering commitment to the HIV community with patient programs that offer support services and financial assistance and ensure Serostim® is accessible to appropriate patients affected by HIV-associated wasting.

The AXIS Center® is our reimbursement and support program dedicated to patients taking Serostim®. The program provides patients with a variety of benefits, including:

  • A dedicated case manager who will be the single point of contact for the patient and their care team
  • Payment assistance programs
  • 24/7 phone support to answer all product-related questions
  • In-home or in-office injection training

Learn more Here

Devoted to Growth

EMD Serono also explored the potential of its recombinant growth hormone in other illnesses. This led to the approval of Saizen® (somatropin) for injection, a product to treat growth hormone deficiency (GHD) in children with growth failure who produce low amounts of growth hormone and adults with GHD that started as a child or as an adult.

Growth hormone deficiency is one of the endocrine (hormonal) disorders that can cause poor growth. Growth hormone is a protein produced by the pituitary gland; if the pituitary gland is malformed/damaged, it may mean that it cannot product growth hormone, which may cause a child’s growth to slow.1

Since its approval, EMD Serono developed a number of devices to help patients administer Saizen® (somatropin) for injection. EMD Serono worked in addition to give these patients the support they need through resources like Connections for Growth.

Important Risk Information

Saizen is a prescription medicine that is used to treat growth hormone deficiency (GHD) in children and adults. Saizen should not be used in children after the growth plates have closed, or in children and adults with any of these medical conditions: a critical illness, serious injury, severe breathing problems, Prader-Willi syndrome who are severely overweight, eye problems caused by high blood sugar, or an allergy to the drug or diluent.

Risks can include serious events such as tumors or cancerous growths, high blood sugar, serious allergic reactions that require medical attention, muscle and joint pain, swelling, itching, and pancreatitis. For complete product details and risks, please refer to the full Prescribing Information and talk to your doctor if you have questions or experience side effects while using Saizen.

Saizen® (somatropin) for injection: Full prescribing information (PDF)

Footnotes

1 Growth Hormone Deficiency Symptoms & Causes. http://www.childrenshospital.org/conditions-and-treatments/conditions/g/growth-hormone-deficiency/symptoms-and-causes. Accessed on April 30, 2018.

Site Exit Disclaimer

You are now leaving the website of EMD Serono, the biopharma business of Merck KGaA, Darmstadt, Germany. This link will either lead to a different website maintained by EMD Serono/its global business, or a different website/resource maintained by 3rd parties.

If you are visiting a 3rd party website, we have no control over the content and are not responsible for and make no representation as to the accuracy or any other aspect of such resource or the privacy practices of such 3rd party. Providing links to a 3rd party website does not constitute EMD Serono’s endorsement of such website or the information or products presented on such website. 

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement